PharmaSource: The External Manufacturing Community Your Biopharma Outsourcing Intelligence Hub Trusted by 50,000+ biopharma manufacturing professionals Sign up for Newsletter LATEST NEWS Lonza Launches Enhanced DNA-to-IND Offering With Six-Month IND Timelines Lonza Launches Enhanced DNA-to-IND Offering With Six-Month IND Timelines Nutraceutical CDMO Guide: Services, Market Size & How to Choose the Right Partner AI Governance in Pharma: FDA-EMA Principles and What Comes Next PAM Theragnostics Partners With FyoniBio on Alzheimer’s Therapy Manufacturing Process Medichem Signs Two U.S. License and Supply Agreements With Somerset Therapeutics Pluri Advances Cellav Commercial Launch With Two U.S.-Listed Aesthetic Products Creative Biostructure Partners With High Q Technologies to Bring Quantum EPR Spectroscopy to Structural Biology CRO Services Oxurion Terminates French CRO Acquisition and Pivots to International Multi-Region CRO Target Alpha Genesis Adds African Green Monkeys to NHP CRO Portfolio for Infectious Disease and Vaccine Research Hosokawa Micron Expands Daresbury CDMO Capacity From One Suite to Three West Pharmaceutical Services Appoints Michel Lagarde as CEO Effective August 2026 Nutraceutical CDMO Guide: Services, Market Size & How to Choose the Right Partner AI Governance in Pharma: FDA-EMA Principles and What Comes Next PAM Theragnostics Partners With FyoniBio on Alzheimer’s Therapy Manufacturing Process PODCASTS How Lonza Is Outgrowing the CDMO Market with Bioconjugation, AI, and Regionalization Beyond the VC Round: Creative Financing Strategies for Biotech’s Bear Market SPOTLIGHT Why Compliance-Driven CDMOs Win Sponsor Contracts RESOURCES CDMO Contract Negotiations Timelines Explained Target Product Profile (TPP) Explained Why Compliance-Driven CDMOs Win Sponsor Contracts UPCOMING EVENTS CDMO Live Europe 2027 CDMO Live Americas 2026 External Manufacturing Leaders Basel 2026
Creative Biostructure Partners With High Q Technologies to Bring Quantum EPR Spectroscopy to Structural Biology CRO Services
Alpha Genesis Adds African Green Monkeys to NHP CRO Portfolio for Infectious Disease and Vaccine Research